IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v39y2016i11d10.1007_s40264-016-0455-4.html
   My bibliography  Save this article

A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals

Author

Listed:
  • Stella Stergiopoulos

    (Tufts Medical School)

  • Carrie A. Brown

    (Tufts Medical School)

  • Thomas Felix

    (Amgen Inc.)

  • Gustavo Grampp

    (Amgen Inc.)

  • Kenneth A. Getz

    (Tufts Medical School)

Abstract

Introduction The under-reporting of adverse drug events (ADEs) is an international health concern. A number of studies have assessed the root causes but, to our knowledge, little information exists relating under-reporting to practices and systems used for the recording and tracking of drug‐related adverse event observations in ambulatory settings, institutional settings, and retail pharmacies. Objectives Our objective was to explore the process for reporting ADEs in US hospitals, ambulatory settings, and retail pharmacies; to explore gaps and inconsistencies in the reporting process; and to identify the causes of under-reporting ADEs in these settings. Methods The Tufts Center for the Study of Drug Development (Tufts CSDD) interviewed 11 thought leaders and conducted a survey between May and August 2014 among US-based healthcare providers (HCPs) in diverse settings to assess their experiences with, and processes for, reporting ADEs. Results A total of 123 individuals completed the survey (42 % were pharmacists; 27 % were nurses; 15 % were physicians; and 16 % were classified as ‘other’). HCPs indicated that the main reasons for under-reporting were difficulty in determining the cause of the ADE, given that most patients receive multiple therapies simultaneously (66 % of respondents); that HCPs lack sufficient time to report ADEs (63 % of respondents); poor integration of ADE-reporting systems (53 % of respondents); and uncertainty about reporting procedures (52 % of respondents). Discussion The results of this pilot study identify that key factors contributing to the under-reporting of ADEs relate to a lack of standardized process, a lack of training and education, and a lack of integrated health information technologies.

Suggested Citation

  • Stella Stergiopoulos & Carrie A. Brown & Thomas Felix & Gustavo Grampp & Kenneth A. Getz, 2016. "A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals," Drug Safety, Springer, vol. 39(11), pages 1117-1127, November.
  • Handle: RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4
    DOI: 10.1007/s40264-016-0455-4
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-016-0455-4
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-016-0455-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Kevin Klein & Joep H. G. Scholl & Niels S. Vermeer & André W. Broekmans & Eugène P. Puijenbroek & Marie L. Bruin & Pieter Stolk, 2016. "Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports," Drug Safety, Springer, vol. 39(2), pages 185-192, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Karen Smith & Su Golder & Abeed Sarker & Yoon Loke & Karen O’Connor & Graciela Gonzalez-Hernandez, 2018. "Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab," Drug Safety, Springer, vol. 41(12), pages 1397-1410, December.
    2. Solomon Shiferaw Nadew & Kidanemariam G/Michael Beyene & Solomon Worku Beza, 2020. "Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia," PLOS ONE, Public Library of Science, vol. 15(1), pages 1-19, January.
    3. Patricia García-Abeijon & Catarina Costa & Margarita Taracido & Maria Teresa Herdeiro & Carla Torre & Adolfo Figueiras, 2023. "Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update," Drug Safety, Springer, vol. 46(7), pages 625-636, July.
    4. Alaa M. Abu Alrub & Yasser Sami Amer & Maher Abdelraheim Titi & Aisha Charmaine A. May & Farheen Shaikh & Maram M. Baksh & Fadi El‐Jardali, 2022. "Barriers and enablers in implementing an electronic incident reporting system in a teaching hospital: A case study from Saudi Arabia," International Journal of Health Planning and Management, Wiley Blackwell, vol. 37(2), pages 854-872, March.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ylenia Ingrasciotta & Paola M. Cutroneo & Ilaria Marcianò & Thijs Giezen & Fabiola Atzeni & Gianluca Trifirò, 2018. "Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction," Drug Safety, Springer, vol. 41(11), pages 1013-1022, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.